Stockscreener 앱 받기
1.15
10.16%
-0.13
시간 외 거래:
1.16
0.01
+0.87%
Acumen Pharmaceuticals Inc 주식(ABOS)의 최신 뉴스
ABOS stock touches 52-week low at $1.28 amid market challenges - Investing.com
ABOS stock touches 52-week low at $1.28 amid market challenges By Investing.com - Investing.com South Africa
Halozyme to Participate in the TD Cowen 45th Annual Healthcare Conference - cnhinews.com
Acumen stock touches 52-week low at $1.54 amid market challenges - MSN
Acumen Pharmaceuticals CEO O'Connell sells shares worth $20,102 - MSN
Acumen Pharmaceuticals COO Barton Russell sells shares worth $4,692 - MSN
SG Americas Securities LLC Grows Stock Holdings in Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) - Defense World
ABOS stock touches 52-week low at $1.31 amid market challenges - MSN
ABOS stock touches 52-week low at $1.31 amid market challenges By Investing.com - Investing.com South Africa
Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Short Interest Update - MarketBeat
Halozyme to Report Fourth Quarter and Full Year 2024 Financial and Operating Results - cnhinews.com
JPMorgan Chase & Co. Has $156,000 Position in Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) - Defense World
Barclays Cuts Teva Pharmaceutical Industries (NYSE:TEVA) Price Target to $26.00 - Defense World
ABOS stock touches 52-week low at $1.52 amid market challenges - Investing.com India
ABOS stock touches 52-week low at $1.52 amid market challenges By Investing.com - Investing.com South Africa
Acumen Pharmaceuticals chief medical officer sells $5,118 in shares - MSN
Acumen Pharmaceuticals chief legal officer sells shares worth $5,434 - MSN
Matt Zuga Sells 28,902 Shares of Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Stock - MarketBeat
Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) CEO Daniel Joseph Oconnell Sells 12,619 Shares - MarketBeat
Acumen Pharmaceuticals CFO sells shares totaling $56,619 - MSN
Promising US Penny Stocks To Consider In January 2025 - Simply Wall St
Analysts Set Expectations for ABOS FY2025 Earnings - Defense World
Acumen Pharmaceuticals CFO sells shares totaling $56,619 By Investing.com - Investing.com South Africa
Acumen Pharmaceuticals CEO O'Connell sells shares worth $20,102 By Investing.com - Investing.com Canada
Brokers Offer Predictions for ABOS FY2025 Earnings - MarketBeat
Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Stock Holdings Lifted by Barclays PLC - Defense World
Short Interest in Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Expands By 9.1% - Defense World
Acumen stock touches 52-week low at $1.54 amid market challenges By Investing.com - Investing.com South Africa
ABOS stock touches 52-week low at $1.68 amid market challenges - Investing.com
Acumen Pharmaceuticals Announces Journal of Prevention of Alzheimer's Disease Publication of the Company's Phase 1 INTERCEPT-AD Study, Including Target Engagement, Dosing Regimen and Safety Findings - The Manila Times
Acumen Pharmaceuticals Announces Journal of Prevention of Alzheimer’s Disease Publication of - The Bakersfield Californian
Acumen's Alzheimer's Drug Shows Promise: Phase 1 Trial Reveals Strong Safety Profile, Plaque Reduction - StockTitan
Acumen Pharmaceuticals CFO Zuga Matt sells $24,366 in stock By Investing.com - Investing.com Australia
Acumen Pharmaceuticals' chief legal officer sells $20,505 in stock By Investing.com - Investing.com Australia
Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Shares Purchased by Geode Capital Management LLC - Defense World
Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Shares Bought by Barclays PLC - Defense World
3.13%
1.23%
자본화:
|
볼륨(24시간):